Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024
Compare Balance Sheet Results of Krebs Biochem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
21.56
11.49
10.07
87.64%
Share Warrants & Outstandings
Total Reserve
-167.80
11.06
-178.86
-1,617.18%
Shareholder's Funds
-146.24
22.54
-168.78
-748.80%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
161.25
0.00
161.25
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
161.25
0.00
161.25
0.00%
Deferred Tax Assets / Liabilities
0.00
0.41
-0.41
-100.00%
Other Long Term Liabilities
45.00
0.00
45.00
0.00%
Long Term Trade Payables
2.44
0.00
2.44
0.00%
Long Term Provisions
3.06
0.03
3.03
10,100.00%
Total Non-Current Liabilities
211.75
0.43
211.32
49,144.19%
Current Liabilities
Trade Payables
18.15
1.35
16.80
1,244.44%
Other Current Liabilities
33.63
0.39
33.24
8,523.08%
Short Term Borrowings
50.96
0.00
50.96
0.00%
Short Term Provisions
0.79
0.00
0.79
0.00%
Total Current Liabilities
103.53
1.74
101.79
5,850.00%
Total Liabilities
169.04
24.72
144.32
583.82%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
314.11
1.05
313.06
29,815.24%
Less: Accumulated Depreciation
168.40
0.62
167.78
27,061.29%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
145.70
0.43
145.27
33,783.72%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.24
0.00
1.24
0.00%
Intangible assets under development
1.85
0.00
1.85
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
10.03
-10.03
-100.00%
Long Term Loans & Advances
9.98
0.00
9.98
0.00%
Other Non Current Assets
0.00
3.56
-3.56
-100.00%
Total Non-Current Assets
158.78
14.02
144.76
1,032.52%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.03
0.78
5.25
673.08%
Sundry Debtors
0.05
0.85
-0.80
-94.12%
Cash and Bank
0.14
1.28
-1.14
-89.06%
Other Current Assets
0.47
0.19
0.28
147.37%
Short Term Loans and Advances
3.56
7.59
-4.03
-53.10%
Total Current Assets
10.26
10.69
-0.43
-4.02%
Net Current Assets (Including Current Investments)
-93.27
8.96
-102.23
-1,140.96%
Total Current Assets Excluding Current Investments
10.26
10.69
-0.43
-4.02%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
169.04
24.72
144.32
583.82%
Contingent Liabilities
8.47
0.63
7.84
1,244.44%
Total Debt
212.21
0.00
212.21
0.00%
Book Value per share (adjusted)
-67.83
19.63
-87.46
-445.54%
Annual - Borrowings
Borrowings 212.21 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.71% vs 5.56% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 45.00 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 146.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.11% vs 0.37% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 10.26 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -41.17% vs 8.59% in Mar 2024






